Cervical Cancer Control: Potential Benefits from Intersectoral Action between Biotechnology and Public Health

被引：0

作者：

Gonzalez-Fernandez, Rebeca S. ^{[1
,2
,3
]}

Gonzalez-Fernandez, Alejandro ^{[4
]}

机构：

[1] Tecnosuma Int SA, Immunoassay Ctr, Bio CubaFarma, Comprehens Womens Hlth, Havana, Cuba

[2] Tecnosuma Int SA, Immunoassay Ctr, Bio CubaFarma, Enrique Cabrera Med Sci Fac, Havana, Cuba

[3] Tecnosuma Int SA, Immunoassay Ctr, Bio CubaFarma, Natl Programs, Havana, Cuba

[4] Julio Diaz Natl Rehabil Hosp, Family Med & Phys Med & Rehabil, Havana, Cuba

来源：

MEDICC REVIEW | 2016年 / 18卷 / 1-2期

关键词：

Cancer; intersectoral action; biotechnology; cervical cancer; early diagnosis; colposcopy; health technologies; Cuba;

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Intersectoral action in health refers to actions led by the health sector based on coordinated national and local policies, strategically oriented to address priority health issues where actions by other sectors can have a decisive impact on health outcomes. A Cuban example of this approach is the joint efforts by the Ministry of Public Health and the biotechnology industry in development and application of technologies for cervical cancer screening, early detection and treatment. The resulting products have been used by the National Health System since 2010, as part of efforts to reduce cervical cancer mortality. This is an example of intersectoral action intended to identify and contribute to solving problems affecting people's well-being and quality of life.

引用

页码：54 / 57

页数：4

共 50 条

[41] Who Really Benefits from 3D-Based Planning of Brachytherapy for Cervical Cancer? [J].

Ha, In Bong ;

Jeong, Bae Kwon ;

Kang, Ki Mun ;

Jeong, Hojin ;

Lee, Yun Hee ;

Choi, Hoon Sik ;

Lee, Jong Hak ;

Choi, Won Jun ;

Shin, Jeong Kyu ;

Song, Jin Ho .

JOURNAL OF KOREAN MEDICAL SCIENCE, 2018, 33 (18)

[42] The Risk of Developing Cervical Cancer in the Elderly: Who Benefits From Screening After the Age of 60? [J].

Ebisch, Renee M. F. ;

Buijssen, Celine ;

Visser, Nicole C. M. ;

Siebers, Albert G. ;

Bekkers, Ruud L. M. .

JOURNAL OF LOWER GENITAL TRACT DISEASE, 2025, 29 (03) :229-234

[43] Environment and cancer in Brazil: an overview from a public health perspective [J].

Koifman, S ;

Koifman, RJ .

MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2003, 544 (2-3) :305-311

[44] Public health insurance and the risk of cancer-specific mortality in patients with cervical cancer: A Chinese prospective cohort study [J].

Yuan, Li ;

Lei, Haike ;

Zou, Dongling ;

Wen, Baogang ;

Li, Xiuying ;

Xu, Qianjie ;

Wang, Ying ;

Zhou, Qi .

FRONTIERS IN PUBLIC HEALTH, 2023, 11

[45] Identification of potential biomarkers in cervical cancer with combined public mRNA and miRNA expression microarray data analysis [J].

Wang, Sizhe ;

Chen, Xiaojin .

ONCOLOGY LETTERS, 2018, 16 (04) :5200-5208

[46] The history and use of cancer registry data by public health cancer control programs in the United States [J].

White, Mary C. ;

Babcock, Frances ;

Hayes, Nikki S. ;

Mariotto, Angela B. ;

Wong, Faye L. ;

Kohler, Betsy A. ;

Weir, Hannah K. .

CANCER, 2017, 123 :4969-4976

[47] Back and forth between cancer treatment and cancer control programs: Insights from the Cuban experience [J].

Lage, Agustin ;

Romero, Teresa .

SEMINARS IN ONCOLOGY, 2018, 45 (1-2) :12-17

[48] Public health concern-driven insights and response of low- and middle-income nations to the World health Organization call for cervical cancer risk eradication [J].

Reza, Sejuti ;

Anjum, Ramisa ;

Khandoker, Rubaiyat Zahan ;

Khan, Saimur Rahman ;

Islam, Md. Rabiul ;

Dewan, Syed Masudur Rahman .

GYNECOLOGIC ONCOLOGY REPORTS, 2024, 54

[49] From cervical cancer elimination to eradication of vaccine-type human papillomavirus: Feasibility, public health strategies and cost-effectiveness [J].

Jit, Mark ;

Prem, Kiesha ;

Benard, Elodie ;

Brisson, Marc .

PREVENTIVE MEDICINE, 2021, 144

[50] The impact of new technologies in cervical cancer screening: Results of the recruitment phase of a large randomised controlled trial from a public health perspective [J].

Giorgi-Rossi, Paolo ;

Segnan, Nereo ;

Zappa, Marco ;

Naldoni, Carlo ;

Zorzi, Manuel ;

Confortini, Massimo ;

Merito, Monica ;

Cuzick, Jack ;

Ronco, Guglielmo .

INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (12) :2729-2734

← 1 2 3 4 5 →